3.87
Sight Sciences Inc stock is traded at $3.87, with a volume of 60,961.
It is down -4.68% in the last 24 hours and up +18.35% over the past month.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
See More
Previous Close:
$4.06
Open:
$3.96
24h Volume:
60,961
Relative Volume:
0.43
Market Cap:
$202.66M
Revenue:
$81.06M
Net Income/Loss:
$-55.55M
P/E Ratio:
-3.3947
EPS:
-1.14
Net Cash Flow:
$-47.98M
1W Performance:
-8.51%
1M Performance:
+18.35%
6M Performance:
+46.04%
1Y Performance:
-42.84%
Sight Sciences Inc Stock (SGHT) Company Profile
Name
Sight Sciences Inc
Sector
Industry
Phone
(415) 889-0550
Address
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
SGHT
Sight Sciences Inc
|
3.87 | 212.61M | 81.06M | -55.55M | -47.98M | -1.14 |
![]()
ABT
Abbott Laboratories
|
131.46 | 230.89B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
106.66 | 156.32B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
389.94 | 149.64B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
93.33 | 119.05B | 34.20B | 4.69B | 5.30B | 3.63 |
![]()
EW
Edwards Lifesciences Corp
|
81.77 | 47.75B | 5.69B | 1.41B | 577.90M | 6.95 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-08-25 | Upgrade | Lake Street | Hold → Buy |
Dec-06-24 | Initiated | UBS | Buy |
Nov-04-24 | Downgrade | Lake Street | Buy → Hold |
Aug-21-24 | Initiated | Lake Street | Buy |
Sep-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
Sep-12-23 | Downgrade | Piper Sandler | Overweight → Neutral |
Sep-12-23 | Downgrade | William Blair | Outperform → Mkt Perform |
Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jul-10-23 | Downgrade | Citigroup | Buy → Neutral |
Jan-06-23 | Upgrade | Stifel | Hold → Buy |
Oct-04-22 | Initiated | Needham | Hold |
Jul-26-22 | Initiated | Stifel | Hold |
Feb-03-22 | Initiated | William Blair | Outperform |
Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
View All
Sight Sciences Inc Stock (SGHT) Latest News
Is Sight Sciences Inc. benefiting from innovation trendsJuly 2025 Opening Moves & Daily Volume Surge Signals - خودرو بانک
Sight Sciences Announces Recognition of the TearCare® - GlobeNewswire
Major Validation: Sight Sciences TearCare System Added to Gold-Standard TFOS DEWS III Dry Eye Guidelines - Stock Titan
Will Sight Sciences Inc. stock recover after earningsMarket Rally & Free AI Powered Buy and Sell Recommendations - خودرو بانک
Is Sight Sciences Inc. stock ready for a breakoutDollar Strength & Consistent Return Investment Signals - Newser
Top chart patterns to watch in Sight Sciences Inc.July 2025 Recap & AI Enhanced Trading Alerts - Newser
What momentum shifts mean for Sight Sciences Inc.Market Movers & Daily Volume Surge Trade Alerts - Newser
What to do if you’re stuck in Sight Sciences Inc.July 2025 Macro Moves & Free Technical Pattern Based Buy Signals - Newser
Ranking Sight Sciences Inc. among high performing stocks via toolsTrade Volume Summary & Advanced Technical Analysis Signals - Newser
Using data tools to time your Sight Sciences Inc. exitMarket Performance Recap & Smart Swing Trading Alerts - Newser
Measuring Sight Sciences Inc.’s beta against major indicesJuly 2025 Price Swings & Capital Efficient Trade Techniques - Newser
Is Sight Sciences Inc. stock a value trapJuly 2025 Institutional & Risk Controlled Swing Alerts - خودرو بانک
Should I average down on Sight Sciences Inc. stockJuly 2025 Big Picture & Daily Profit Focused Screening - kpenews.com
Using R and stats models for Sight Sciences Inc. forecastingJobs Report & Free Community Consensus Stock Picks - Newser
Will Sight Sciences Inc. stock recover after recent dropQuarterly Trade Review & Weekly Market Pulse Updates - Newser
Predicting Sight Sciences Inc. trend using moving averagesQuarterly Portfolio Summary & Intraday High Probability Alerts - Newser
Sight Sciences, Inc. (NASDAQ:SGHT) Q2 2025 Earnings Call Transcript - MSN
Will Sight Sciences Inc. continue its uptrendJuly 2025 Weekly Recap & Technical Analysis for Trade Confirmation - Newser
Is Sight Sciences Inc. building a consolidation baseGold Moves & Real-Time Chart Breakout Alerts - Newser
Quant Tools Rank Sight Sciences Inc. as High Risk High Reward getLinesFromResByArray error: size == 0 - thegnnews.com
Can swing trading help recover from Sight Sciences Inc. lossesTrade Risk Summary & Stepwise Entry and Exit Trade Signals - Newser
Can volume confirm reversal in Sight Sciences Inc.Jobs Report & Community Verified Watchlist Alerts - Newser
What machine learning models say about Sight Sciences Inc.July 2025 Final Week & Reliable Volume Spike Trade Alerts - Newser
How to escape a deep drawdown in Sight Sciences Inc.2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - Newser
Can momentum traders help lift Sight Sciences Inc.Quarterly Portfolio Report & Low Volatility Stock Recommendations - Newser
How high can Sight Sciences Inc. stock goMarket Performance Report & Reliable Breakout Forecasts - Newser
Technical signs of recovery in Sight Sciences Inc.Trade Ideas & AI Driven Stock Reports - Newser
Analyzing recovery setups for Sight Sciences Inc. investorsTrade Volume Summary & Entry Point Confirmation Signals - Newser
Sight Sciences Inc Stock (SGHT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):